282 related articles for article (PubMed ID: 9723280)
1. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer HH
Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
[No Abstract] [Full Text] [Related]
2. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
Budde K; Fritsche L; Smettan S; Schönberger B; Loening SA; Mai I; Bauer S; Waiser J; Neumayer HH
Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
[No Abstract] [Full Text] [Related]
3. FK506 rescue therapy for acute renal allograft rejection.
Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
[No Abstract] [Full Text] [Related]
4. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
[No Abstract] [Full Text] [Related]
5. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
Becker G; Witzke O; Friedrich J; Wagner K; Heemann U; Philipp T
Transplant Proc; 1996 Dec; 28(6):3169-70. PubMed ID: 8962228
[No Abstract] [Full Text] [Related]
6. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
Naraghi RM; Smith D; Shapiro R; Vivas CA; Gritsch HA; Scantlebury VP; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE; Jordan ML
Transplant Proc; 1997; 29(1-2):310. PubMed ID: 9123013
[No Abstract] [Full Text] [Related]
7. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
Hu RH; Lee PH; Tsai MK
Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
[No Abstract] [Full Text] [Related]
8. Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Budde K; Smettan S; Fritsche L; Waiser J; Neumayer HH
Transplant Proc; 2002 Aug; 34(5):1594-6. PubMed ID: 12176499
[No Abstract] [Full Text] [Related]
9. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
10. Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up.
Citterio F; Scatà MC; Romagnoli J; Pozzetto U; Nanni G; Castagneto M
Transplant Proc; 2002 Aug; 34(5):1685-6. PubMed ID: 12176535
[No Abstract] [Full Text] [Related]
11. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
Wang XH; Tang XD; Xu D
Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
[No Abstract] [Full Text] [Related]
12. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Turner CD; Bruce DS; Cronin DC; Loss GE; Grewal H; Siegel C; Millis JM; Newell KA; Davis B; Todo T; Thistlethwaite JR; Woodle ES
Transplant Proc; 1998 Jun; 30(4):1234-5. PubMed ID: 9636501
[No Abstract] [Full Text] [Related]
13. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
[No Abstract] [Full Text] [Related]
14. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
15. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
16. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
Blume C; Hollenbeck M; Ivens K; Heering P; Hetzel GR; Grabensee B
Transplant Proc; 2001; 33(7-8):3161-3. PubMed ID: 11750357
[No Abstract] [Full Text] [Related]
17. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
19. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
Woodle ES; Thistlethwaite JR; Gordon JH
Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
[No Abstract] [Full Text] [Related]
20. Five-year experience with tacrolimus rescue for renal allograft rejection.
Jordan ML; Naraghi RN; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
Transplant Proc; 1997; 29(1-2):306. PubMed ID: 9123009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
